4D Molecular Therapeutics, Inc. (FDMT)
USD 2.51
(-5.28%)
USD 2.51
(-5.28%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -234.43 Million USD | -15.76% |
| 2022 | -202.51 Million USD | 32.26% |
| 2021 | -298.98 Million USD | -8.04% |
| 2020 | -276.72 Million USD | -457.33% |
| 2019 | -49.65 Million USD | 45.89% |
| 2018 | -91.76 Million USD | -284.74% |
| 2017 | -23.85 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -261.42 Million USD | -11.51% |
| 2024 Q2 | -175.4 Million USD | 32.9% |
| 2023 Q3 | -260.52 Million USD | 11.6% |
| 2023 Q4 | -234.43 Million USD | 10.01% |
| 2023 FY | -234.43 Million USD | -15.76% |
| 2023 Q1 | -186.17 Million USD | -413.92% |
| 2023 Q2 | -294.71 Million USD | -58.3% |
| 2022 Q3 | -91.74 Million USD | 4.91% |
| 2022 Q4 | -36.22 Million USD | 60.51% |
| 2022 Q2 | -96.48 Million USD | -63.12% |
| 2022 FY | -202.51 Million USD | 32.26% |
| 2022 Q1 | -59.15 Million USD | 56.68% |
| 2021 Q1 | -259.86 Million USD | 6.09% |
| 2021 FY | -298.98 Million USD | -8.04% |
| 2021 Q4 | -136.55 Million USD | -50.08% |
| 2021 Q3 | -90.98 Million USD | 62.67% |
| 2021 Q2 | -243.74 Million USD | 6.2% |
| 2020 Q4 | -276.72 Million USD | -211.79% |
| 2020 FY | -276.72 Million USD | -457.33% |
| 2020 Q1 | 49.65 Million USD | 200.0% |
| 2020 Q3 | -88.75 Million USD | 0.0% |
| 2019 Q3 | 72.86 Million USD | 200.0% |
| 2019 FY | -49.65 Million USD | 45.89% |
| 2019 Q4 | -49.65 Million USD | -168.14% |
| 2019 Q1 | -72.86 Million USD | 20.59% |
| 2019 Q2 | -72.86 Million USD | 0.0% |
| 2018 Q4 | -91.76 Million USD | 0.0% |
| 2018 FY | -91.76 Million USD | -284.74% |
| 2018 Q1 | 23.85 Million USD | 0.0% |
| 2018 Q3 | -91.76 Million USD | 0.0% |
| 2017 FY | -23.85 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | 61.25 Million USD | 482.711% |
| Jaguar Health, Inc. | 29.39 Million USD | 897.649% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 25.976% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -1591.953% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 112.537% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -1296.373% |
| ContextLogic Inc. | -232 Million USD | -1.05% |
| MiMedx Group, Inc. | -33.9 Million USD | -591.534% |
| MEI Pharma, Inc. | -3.7 Million USD | -6227.584% |
| AlloVir, Inc. | -62.69 Million USD | -273.95% |
| Novavax, Inc. | -298.29 Million USD | 21.407% |
| Aptorum Group Limited | 1.35 Million USD | 17375.538% |
| Ardelyx, Inc. | 34.51 Million USD | 779.291% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 5577.5% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 3500.3% |
| Vaxcyte, Inc. | -368.22 Million USD | 36.334% |
| Precigen, Inc. | -481 Thousand USD | -48639.501% |
| Pharming Group N.V. | 109.8 Million USD | 313.505% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 3.27% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -1247.649% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 943.511% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -33.788% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -10018.009% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1165.868% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1165.868% |
| Bicycle Therapeutics plc | -481.46 Million USD | 51.308% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -3201.93% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -3900.631% |
| Acelyrin, Inc. | -216.9 Million USD | -8.084% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -13498.434% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -3346.083% |
| Senti Biosciences, Inc. | 1.74 Million USD | 13573.391% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -26.992% |
| AbCellera Biologics Inc. | -55.94 Million USD | -319.087% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -3767.321% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 748.279% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 37430.732% |
| Chimerix, Inc. | -25.51 Million USD | -818.748% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -100.295% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 1973.847% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 3464.444% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 1870.806% |
| Elevation Oncology, Inc. | -19.11 Million USD | -1126.263% |
| Alkermes plc | -166.73 Million USD | -40.601% |
| Fortress Biotech, Inc. | 7.66 Million USD | 3158.539% |
| Fortress Biotech, Inc. | 7.66 Million USD | 3158.539% |
| Agenus Inc. | 274.13 Million USD | 185.519% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -112.089% |
| Dyadic International, Inc. | -6.37 Million USD | -3575.656% |
| ImmuCell Corporation | 10.99 Million USD | 2233.076% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -1371.393% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -52.088% |
| Lantern Pharma Inc. | -21.7 Million USD | -980.192% |
| Immix Biopharma, Inc. | -17.5 Million USD | -1238.891% |
| Incyte Corporation | -3.17 Billion USD | 92.616% |
| IO Biotech, Inc. | -140.69 Million USD | -66.623% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 4492.674% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -2644.143% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 2027.418% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -202.691% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -4675.657% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -81.574% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 1456.853% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 311.452% |
| NextCure, Inc. | -6.47 Million USD | -3519.531% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -364.222% |
| Onconetix, Inc. | 5.33 Million USD | 4497.257% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -3575.137% |
| Opthea Limited | 28.15 Million USD | 932.593% |
| PDS Biotechnology Corporation | -32.7 Million USD | -616.738% |
| PureTech Health plc | -167.19 Million USD | -40.216% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 2399.529% |
| Seer, Inc. | -4.24 Million USD | -5429.175% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -4078.714% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 1764.917% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 235079.803% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -669.655% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -39.353% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 244.945% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -321.543% |
| ChromaDex Corporation | -24.04 Million USD | -874.871% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -2986.322% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -890.147% |
| CRISPR Therapeutics AG | -150.84 Million USD | -55.416% |
| Precision BioSciences, Inc. | -85.41 Million USD | -174.484% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 480.172% |
| Innoviva, Inc. | 255.56 Million USD | 191.734% |
| Summit Therapeutics Inc. | 34.67 Million USD | 776.118% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -875.317% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -319.657% |
| ESSA Pharma Inc. | -33.62 Million USD | -597.281% |
| GlycoMimetics, Inc. | -40.98 Million USD | -472.015% |
| GT Biopharma, Inc. | -1.02 Million USD | -22861.508% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -245.864% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -74.85% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -711.987% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -311096.804% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -659.63% |
| Aptose Biosciences Inc. | -8.19 Million USD | -2760.782% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -7392.351% |
| Soligenix, Inc. | -4.95 Million USD | -4634.574% |
| Century Therapeutics, Inc. | 847 Thousand USD | 27778.512% |
| Kura Oncology, Inc. | -20.11 Million USD | -1065.31% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -472.831% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -2691.581% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 12969.169% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -7233.031% |
| Autolus Therapeutics plc | -186.59 Million USD | -25.637% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -375.493% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 14.996% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 784.128% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 242.629% |
| GRI Bio, Inc. | -1.79 Million USD | -12967.837% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -2509.772% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -604.925% |
| IGM Biosciences, Inc. | -72.6 Million USD | -222.889% |
| INmune Bio, Inc. | -25.41 Million USD | -822.581% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 255.307% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -362.775% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1342.745% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -8026.274% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 716.696% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -469.229% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 835.258% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 162.028% |
| Verastem, Inc. | -37.27 Million USD | -528.888% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -2483.897% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -352.04% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -1448.973% |
| Histogen Inc. | -7.48 Million USD | -3031.254% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -985.014% |
| Surrozen, Inc. | -32.66 Million USD | -617.723% |
| Organovo Holdings, Inc. | -1.5 Million USD | -15456.536% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -5477.202% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 1336.469% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 9061.659% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 5740.929% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -2697.194% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -439.655% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -1508.282% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 25.996% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -32367.8% |
| Apollomics, Inc. | -27.39 Million USD | -755.766% |
| Amarin Corporation plc | -191.04 Million USD | -22.716% |
| Mesoblast Limited | 55.96 Million USD | 518.914% |
| Turnstone Biologics Corp. | -14.58 Million USD | -1507.495% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -826.922% |
| Synaptogenix, Inc. | -28.66 Million USD | -717.951% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -24946.688% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 581.074% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -27094.06% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -3126.458% |
| Exelixis, Inc. | -73.05 Million USD | -220.927% |
| Better Therapeutics, Inc. | -860 Thousand USD | -27160.116% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -876.292% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 2.873% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 31949.997% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -3051.825% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 18795.136% |
| Gritstone bio, Inc. | 39.49 Million USD | 693.662% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -178.756% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -8806.707% |
| Avid Bioservices, Inc. | 169.72 Million USD | 238.125% |
| Insmed Incorporated | 721.62 Million USD | 132.488% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -2464.532% |
| MediWound Ltd. | -5.32 Million USD | -4305.054% |
| OmniAb, Inc. | 9.2 Million USD | 2647.398% |
| Alector, Inc. | -35.63 Million USD | -557.847% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 372.693% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -4657.244% |
| Zai Lab Limited | -775 Million USD | 69.75% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 168.84% |
| Aura Biosciences, Inc. | -21.52 Million USD | -989.138% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -184.235% |
| Immunic, Inc. | -45.34 Million USD | -417.064% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | -21.335% |
| Veracyte, Inc. | -203.82 Million USD | -15.019% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 136.729% |
| FibroGen, Inc. | 56.76 Million USD | 512.981% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 2732.645% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -8192.543% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -11223.555% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 105.107% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -6916.971% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -41.258% |
| TG Therapeutics, Inc. | 17.86 Million USD | 1412.49% |
| Galecto, Inc. | -21.21 Million USD | -1005.001% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -885.651% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 114.938% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -857.981% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -1937.342% |
| XBiotech Inc. | -200.02 Million USD | -17.205% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -178.756% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 5277.496% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -564.824% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -203.604% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 4219.434% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -37.568% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -153.791% |
| Vaxxinity, Inc. | 10.13 Million USD | 2413.827% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 131.841% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -2077.255% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -255.445% |
| NexImmune, Inc. | -3.13 Million USD | -7381.293% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -6690.015% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -1451.387% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -765.081% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -2511.805% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -188089.444% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -477.83% |
| Ainos, Inc. | 4.07 Million USD | 5848.924% |
| Pluri Inc. | 22.82 Million USD | 1126.926% |
| Prothena Corporation plc | -608.34 Million USD | 61.463% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -97.411% |
| Celularity Inc. | 65.19 Million USD | 459.621% |
| Rallybio Corporation | -24.1 Million USD | -872.687% |
| Cue Biopharma, Inc. | -33.81 Million USD | -593.211% |
| MeiraGTx Holdings plc | -40.3 Million USD | -481.701% |
| Omeros Corporation | 331.17 Million USD | 170.789% |
| Humacyte, Inc. | -22.48 Million USD | -942.591% |
| Immunocore Holdings plc | -358.59 Million USD | 34.623% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -853.965% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -658.671% |
| Blueprint Medicines Corporation | 702.83 Million USD | 133.356% |
| CalciMedica, Inc. | -5.53 Million USD | -4139.367% |
| Cabaletta Bio, Inc. | -188.22 Million USD | -24.555% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -2195.252% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -485.551% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -605.01% |
| Pulmatrix, Inc. | -10.41 Million USD | -2150.523% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -3822.319% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -514.643% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -110.442% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -291.093% |
| Cytokinetics, Incorporated | 642.37 Million USD | 136.496% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -3926.052% |
| Nutriband Inc. | -251.65 Thousand USD | -93057.353% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -587.116% |
| Vor Biopharma Inc. | 4.3 Million USD | 5552.023% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 96.116% |
| Evogene Ltd. | -19.63 Million USD | -1094.036% |
| ProKidney Corp. | -56.23 Million USD | -316.881% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -381.667% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -2437.97% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 117.189% |
| CorMedix Inc. | -43.05 Million USD | -444.537% |
| BioLineRx Ltd. | 7.33 Million USD | 3295.706% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -753.585% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 608.022% |
| Atai Life Sciences N.V. | -28.55 Million USD | -720.915% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 10610.377% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -927.511% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 1421.889% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -212.275% |
| MediciNova, Inc. | -50.78 Million USD | -361.64% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -197.49% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -1042073.816% |
| GeoVax Labs, Inc. | -6.45 Million USD | -3533.224% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | -17.324% |
| Biomea Fusion, Inc. | -166.57 Million USD | -40.744% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -30.989% |
| Mereo BioPharma Group plc | -51.46 Million USD | -355.492% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -147.182% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 20.194% |
| Absci Corporation | -72.59 Million USD | -222.925% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 5234.406% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -148.842% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -144.981% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -499.997% |
| Allakos Inc. | -24.97 Million USD | -838.687% |
| Imunon, Inc. | -4.21 Million USD | -5463.484% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -1490.266% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -73.144% |
| BioAtla, Inc. | -109.01 Million USD | -115.058% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 31949.997% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -24866.667% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 2059.193% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -1005.678% |
| XOMA Corporation | -29 Million USD | -708.403% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -1315.682% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -2500.233% |
| aTyr Pharma, Inc. | -7.44 Million USD | -3047.228% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -88.097% |
| Akero Therapeutics, Inc. | -208.16 Million USD | -12.621% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -186.671% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -152.727% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -27186.006% |
| Akari Therapeutics, Plc | -3.84 Million USD | -5997.191% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 14545.649% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 116.977% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -19631.512% |
| UroGen Pharma Ltd. | 4.39 Million USD | 5439.034% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 306.587% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 325878.883% |
| Orgenesis Inc. | 21.78 Million USD | 1176.189% |
| Entera Bio Ltd. | -10.62 Million USD | -2105.636% |
| GH Research PLC | -78.07 Million USD | -200.264% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -951.853% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -779.392% |
| Xencor, Inc. | 29.64 Million USD | 890.841% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -11801.491% |
| Replimune Group, Inc. | 1.41 Million USD | 16703.187% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -95624.517% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -85.447% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -19631.512% |
| Portage Biotech Inc. | -4.98 Million USD | -4606.625% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -1042073.816% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -254.552% |
| OncoCyte Corporation | -6.56 Million USD | -3472.101% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 26223.647% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -5046.079% |
| Purple Biotech Ltd. | -14.13 Million USD | -1558.205% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -886.854% |
| scPharmaceuticals Inc. | -6.54 Million USD | -3481.925% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -1304.473% |
| HilleVax, Inc. | -165.48 Million USD | -41.667% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -9137.076% |
| Tharimmune, Inc. | -10.93 Million USD | -2043.845% |
| Genprex, Inc. | -6.73 Million USD | -3379.518% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 36.434% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -165.02% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -16633.547% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -6967.857% |
| OKYO Pharma Limited | -826.84 Thousand USD | -28253.095% |
| Savara Inc. | 153 Thousand USD | 153326.797% |
| Curis, Inc. | -23.88 Million USD | -881.442% |
| Daré Bioscience, Inc. | -5.15 Million USD | -4445.193% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -30110.486% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -3676.369% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 19883.713% |
| BeiGene, Ltd. | -2.25 Billion USD | 89.595% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 2000.045% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 61.454% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | -26.323% |
| Erasca, Inc. | -37.21 Million USD | -529.936% |
| bluebird bio, Inc. | 108.57 Million USD | 315.93% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -18103.143% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 161.898% |
| DBV Technologies S.A. | -126.98 Million USD | -84.616% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -18103.143% |
| Moderna, Inc. | -2.9 Billion USD | 91.935% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -2164.654% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -2057.131% |
| Molecular Templates, Inc. | 707 Thousand USD | 33259.406% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -647.305% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 167.638% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -185.683% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -155.573% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -626.441% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -581.979% |
| MacroGenics, Inc. | -66.98 Million USD | -249.984% |
| RenovoRx, Inc. | -1.17 Million USD | -19886.104% |
| Adicet Bio, Inc. | -138.78 Million USD | -68.919% |
| Prime Medicine, Inc. | -27.94 Million USD | -739.043% |
| Aditxt, Inc. | 18.12 Million USD | 1393.739% |
| Adagene Inc. | -87.62 Million USD | -167.539% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -5528.161% |
| Quantum-Si incorporated | -118.55 Million USD | -97.742% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 751.123% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -3036.622% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -383.286% |
| SciSparc Ltd. | -2.06 Million USD | -11252.881% |
| Vericel Corporation | 1.27 Million USD | 18458.418% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1854.994% |
| Minerva Neurosciences, Inc. | 41 Million USD | 671.738% |
| Generation Bio Co. | 31.44 Million USD | 845.475% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -33.686% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -658.131% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 301.073% |
| Invivyd, Inc. | -198.47 Million USD | -18.119% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -159.706% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -9677.626% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -231.172% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -3334.974% |
| 2seventy bio, Inc. | 181.71 Million USD | 229.014% |
| ADMA Biologics, Inc. | 90.06 Million USD | 360.295% |
| Clene Inc. | 3.34 Million USD | 7119.072% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -2481.137% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -989.847% |
| GeoVax Labs, Inc. | -6.45 Million USD | -3533.224% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 31.874% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -801.692% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 231.954% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -5629.761% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 4786.865% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -4400.614% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -79.915% |
| Evaxion Biotech A/S | 5.28 Million USD | 4534.347% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -108.263% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -78.587% |
| Trevena, Inc. | 2.25 Million USD | 10482.507% |
| Surrozen, Inc. | -32.66 Million USD | -617.723% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -355.129% |
| Cingulate Inc. | 3.08 Million USD | 7704.966% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -7882.193% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 3361.959% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -2423.208% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -195.547% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -78.344% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -122.127% |
| Clearmind Medicine Inc. | -3.94 Million USD | -5846.198% |
| Kronos Bio, Inc. | -36.05 Million USD | -550.239% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 2591.625% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 16177.955% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -332.094% |
| Statera Biopharma, Inc. | 14.41 Million USD | 1726.182% |
| ImmunityBio, Inc. | 618.22 Million USD | 137.921% |
| Korro Bio, Inc. | -132.94 Million USD | -76.344% |
| Kineta, Inc. | -4.54 Million USD | -5062.673% |
| BioVie Inc. | -17.73 Million USD | -1222.086% |
| Codexis, Inc. | -43.27 Million USD | -441.788% |
| Celularity Inc. | 65.19 Million USD | 459.621% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -7297.823% |
| Celcuity Inc. | 6.78 Million USD | 3555.984% |
| Virax Biolabs Group Limited | -3.36 Million USD | -6867.04% |
| Cibus, Inc. | -8.07 Million USD | -2802.166% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -5443.556% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 5229.912% |
| IN8bio, Inc. | -16.38 Million USD | -1330.453% |
| Kodiak Sciences Inc. | -103.87 Million USD | -125.691% |
| Annexon, Inc. | -193.75 Million USD | -20.997% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 651313.889% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -1239.717% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -6573.413% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 122.237% |
| Eyenovia, Inc. | 1.25 Million USD | 18725.298% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 971.351% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -7129.016% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -605.137% |
| Arcellx, Inc. | -296.95 Million USD | 21.054% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -1101.871% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -298.194% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -1031.071% |
| Moolec Science SA | 117.61 Thousand USD | 199424.072% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -510.529% |
| Geron Corporation | 14.76 Million USD | 1688.219% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -518.274% |
| Royalty Pharma plc | 5.65 Billion USD | 104.143% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -65.772% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -3254.168% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -4271.493% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -66.585% |
| Humacyte, Inc. | -22.48 Million USD | -942.591% |
| Structure Therapeutics Inc. | -124.33 Million USD | -88.547% |
| 89bio, Inc. | -289.05 Million USD | 18.895% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -828.758% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -13048.458% |
| Genelux Corporation | -6.89 Million USD | -3298.13% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -654.812% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 380.43% |
| Notable Labs, Ltd. | -9.77 Million USD | -2298.087% |
| Liquidia Corporation | -80.17 Million USD | -192.403% |
| Mustang Bio, Inc. | -3.73 Million USD | -6175.08% |
| Immunovant, Inc. | -635.22 Million USD | 63.094% |
| Quantum-Si incorporated | -118.55 Million USD | -97.742% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -1234.759% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -5558.629% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 3020.605% |
| Acasti Pharma Inc. | -23 Million USD | -919.07% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -6862.312% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1342.745% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -70.203% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -7422.778% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -954.503% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -1162.518% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -38.492% |
| PepGen Inc. | -60.67 Million USD | -286.413% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -920.356% |
| United Therapeutics Corporation | -507.7 Million USD | 53.824% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -1125.75% |
| Solid Biosciences Inc. | -47.75 Million USD | -390.968% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -27094.06% |
| Immuneering Corporation | -54.94 Million USD | -326.692% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -5477.202% |
| Silo Pharma, Inc. | -3.52 Million USD | -6552.001% |
| Belite Bio, Inc | -87.27 Million USD | -168.631% |
| XOMA Corporation | -29 Million USD | -708.403% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -231.608% |
| Bionomics Limited | 227 Million USD | 203.272% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -101.611% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -9155.31% |
| uniQure N.V. | -102.95 Million USD | -127.717% |
| Cassava Sciences, Inc. | -121.13 Million USD | -93.532% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -5528.161% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 672.482% |
| Forte Biosciences, Inc. | -11.96 Million USD | -1860.012% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -7476.66% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 221266.981% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -7129.016% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 2732.645% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -3061.232% |
| Altimmune, Inc. | -134.48 Million USD | -74.319% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 218.364% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -9155.31% |
| Compugen Ltd. | -12.9 Million USD | -1716.778% |
| Peak Bio, Inc. | 10.34 Million USD | 2367.248% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -82739.929% |
| Benitec Biopharma Inc. | -50.58 Million USD | -363.479% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -124.69% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 1293.367% |
| Zura Bio Limited | -99.8 Million USD | -134.893% |
| PolyPid Ltd. | 6.17 Million USD | 3899.627% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 416.294% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 1293.367% |
| Instil Bio, Inc. | 75.35 Million USD | 411.098% |
| argenx SE | -2.02 Billion USD | 88.445% |
| Immunome, Inc. | -97.02 Million USD | -141.615% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -942.174% |
| Verona Pharma plc | -220.44 Million USD | -6.348% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -226.773% |
| Shattuck Labs, Inc. | -121.42 Million USD | -93.073% |
| CervoMed Inc. | -7.79 Million USD | -2908.362% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | -26.382% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -5261.011% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -77.954% |
| Moolec Science SA | 117.61 Thousand USD | 199424.072% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -10146.475% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 1574.597% |
| AnaptysBio, Inc. | -18.15 Million USD | -1191.593% |
| Design Therapeutics, Inc. | -18.15 Million USD | -1191.664% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -233.097% |
| NeurAxis, Inc. | 145.7 Thousand USD | 161003.912% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 2187.224% |
| Lumos Pharma, Inc. | -28.49 Million USD | -722.788% |
| Achilles Therapeutics plc | -126.92 Million USD | -84.707% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -226.773% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -35652.063% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -1028.521% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 16177.955% |
| Nutriband Inc. | -251.65 Thousand USD | -93057.353% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -1679.948% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -3051.035% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 168.912% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 1087.727% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 47.609% |
| Palisade Bio, Inc. | -12.06 Million USD | -1843.439% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -67.084% |
| Beam Therapeutics Inc. | -262.72 Million USD | 10.766% |
| Neurogene Inc. | -131.95 Million USD | -77.664% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 1174.61% |
| AEON Biopharma, Inc. | -4.88 Million USD | -4704.037% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 37.847% |
| Sesen Bio, Inc. | -112.55 Million USD | -108.29% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -134.766% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -9885.42% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -500.72% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -181.498% |
| Athira Pharma, Inc. | -88.99 Million USD | -163.415% |
| Vaccinex, Inc. | -1.28 Million USD | -18101.63% |
| HCW Biologics Inc. | 2.85 Million USD | 8306.636% |
| XOMA Corporation | -29 Million USD | -708.403% |
| Nektar Therapeutics | 210.24 Million USD | 211.509% |
| Arvinas, Inc. | -313.8 Million USD | 25.291% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 14545.649% |
| Merus N.V. | -192.88 Million USD | -21.543% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 490.826% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -3279.029% |
| Rezolute, Inc. | -68.16 Million USD | -243.911% |
| Clene Inc. | 3.34 Million USD | 7119.072% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -1677.789% |
| BeyondSpring Inc. | -13.75 Million USD | -1604.377% |
| Synlogic, Inc. | -6.68 Million USD | -3406.911% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 20773.457% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -2672.762% |
| Peak Bio, Inc. | 10.34 Million USD | 2367.248% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -184.442% |
| Krystal Biotech, Inc. | -350.23 Million USD | 33.063% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 288.872% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -38.723% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -7325.604% |
| MannKind Corporation | 143.89 Million USD | 262.918% |
| Ikena Oncology, Inc. | -109.15 Million USD | -114.772% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -2996.513% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -608.269% |
| Gossamer Bio, Inc. | 180.35 Million USD | 229.986% |
| CohBar, Inc. | -5.93 Million USD | -3852.919% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -688.077% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 5234.406% |
| Legend Biotech Corporation | -949.39 Million USD | 75.307% |
| Mural Oncology plc | -255.84 Million USD | 8.367% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 827.726% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -4876.753% |
| Disc Medicine, Inc. | -358.28 Million USD | 34.566% |
| Champions Oncology, Inc. | 4.81 Million USD | 4971.924% |
| REGENXBIO Inc. | 54.76 Million USD | 528.055% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -87081.442% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -55.232% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -2501.385% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -190.566% |
| Vaxart, Inc. | -8.24 Million USD | -2744.764% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -367.192% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -84.356% |
| Cellectis S.A. | -43.85 Million USD | -434.573% |
| Longeveron Inc. | -2.9 Million USD | -7961.795% |
| Repare Therapeutics Inc. | -107.85 Million USD | -117.357% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 124.209% |
| Inozyme Pharma, Inc. | 12 Million USD | 2052.991% |
| Revolution Medicines, Inc. | -608.2 Million USD | 61.454% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -18959.919% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 11.572% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -56.216% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -1398.287% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -31580.676% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 97.549% |
| Denali Therapeutics Inc. | -74.86 Million USD | -213.146% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1854.994% |
| Veru Inc. | 4.77 Million USD | 5004.572% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -1984.626% |
| Cingulate Inc. | 3.08 Million USD | 7704.966% |
| Passage Bio, Inc. | 4.58 Million USD | 5213.13% |
| Context Therapeutics Inc. | -14.44 Million USD | -1522.421% |
| Exicure, Inc. | 5.84 Million USD | 4108.155% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | -1.763% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -492.461% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 1594.086% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -298.56% |
| Nuvalent, Inc. | -335.38 Million USD | 30.1% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 13617.353% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -214.757% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -2537.087% |
| OmniAb, Inc. | 9.2 Million USD | 2647.398% |
| Anew Medical, Inc. | 1.43 Million USD | 16465.985% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 1531.086% |
| Lipocine Inc. | -4.75 Million USD | -4830.749% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -113.458% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 1639.21% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -362.775% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 1041.817% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -3388.127% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -256.141% |
| Ocugen, Inc. | -32.52 Million USD | -620.879% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -173.955% |
| Q32 Bio Inc. | -37.94 Million USD | -517.785% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -37230.732% |
| Alumis Inc. Common Stock | -13.52 Million USD | -1632.848% |
| Equillium, Inc. | -22.39 Million USD | -946.968% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -816.916% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -618.542% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -94463.459% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 274.898% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 7430.738% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 71478.726% |
| Dominari Holdings Inc. | 195 Thousand USD | 120324.103% |
| Edesa Biotech, Inc. | -5.26 Million USD | -4351.13% |
| vTv Therapeutics Inc. | -8.91 Million USD | -2529.102% |
| Bio-Techne Corporation | 267.74 Million USD | 187.559% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -1346.338% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -98.517% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -2689.92% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -1753.11% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 4.358% |
| Nkarta, Inc. | 57.29 Million USD | 509.147% |
| BioCardia, Inc. | 212 Thousand USD | 110683.491% |
| Iterum Therapeutics plc | 13.43 Million USD | 1844.583% |